loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 202002 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Strides Pharma Science

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 STRIDES PHARMA (1)

    filter

    01 CREAM;TOPICAL (1)

    filter

    01 DISCN (1)

    filter

    01 IMIQUIMOD (1)

    filter

    01 No (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    IMIQUIMOD

    PDF Supplier PDF
    URL Supplier Web Content
    CREAM; TOPICAL
    5%
    2014-06-24
    202002
    IMIQUIMOD
    DISCN
    No
    Strides Pharma Science

    CPhI Worldwide, Milan

    Booth #5C33

    envelop Contact Supplier

    Looking for FDA Orange Book APPLICATION 202002

    Looking for FDA Orange Book APPLICATION 202002 1

    19

    Strides Pharma Science, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    They are recognized for Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

    One of their notable products is IMIQUIMOD, with a corresponding application number 202002.

    Regulatory Information DISCN

    With a dosage strength 5%

    Dosage Form Route CREAM; TOPICAL

    Reference Listed Drug No

    Approved since 2014-06-24

    Post Enquiry
    POST ENQUIRY